Archived Seminar: Design and Optimization of CAR T cells and their Application to Glioblastoma
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Design and Optimization of CAR T Cells and Their Application to Glioblastoma
Date: Sept. 18, 2020
Time: 11:00 a.m. - 12:00 p.m.
Abstract
Encouraging clinical experience with chimeric antigen receptor (CAR) T cells supports the notion that even immune privileged sites such as the brain may be amenable to CAR therapy. In the context of hematologic B-cell malignancies, CD19-CARs have been shown to accumulate in the cerebrospinal fluid (CSF) and reduce the incidence of metastatic disease in the central nervous system. However, brain tumors pose significant challenges for CAR T cell therapy, including heterogeneous antigen expression, immunosuppressive networks in the tumor microenvironment that limit CAR T cell function and persistence, and suboptimal T cell trafficking to the tumor site. This presentation will describe our clinical experience with CAR T cells for glioblastoma (GBM), one of the most common and aggressive primary malignant brain tumors, and our efforts to overcome therapeutic challenges.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home ItemPioneers in Biomedical Research: Inter-Organelle Communication Pathways and Dynamics Revealed by Imaging , home
Sept. 9, 2022, 11 a.m. | Jennifer Lippincott-Schwartz, Ph.D. | Pioneers in Biomedical Research Seminar Series
-
Home ItemPioneers in Biomedical Research: Regulation of Endothelial Cell Specialization , home
Sept. 16, 2022, 11 a.m. | Karen K. Hirschi, Ph.D. | Pioneers in Biomedical Research Seminar Series
-
Home ItemMedical Scholar Lecture: Albinism: Can It Become a Treatable Disease? , home
Sept. 16, 2022, 1 to 2 p.m. | Brian Brooks, M.D., Ph.D. | Timothy A. Johnson Medical Scholar Lecture Series
-
Home ItemPublic Lecture: Socially-Directed Science and Technology: Design at the Intersection of History, Sustainability, and Equity with Applications to Biotechnology and Biomaterials , home
Sept. 22, 2022, 5:30 p.m. | Christine Ortiz, Ph.D. | Maury Strauss Distinguished Public Lecture
-
Home ItemPioneers in Biomedical Research: Connectomics of Addiction Recovery , home
Sept. 23, 2022, 11:00 am. | Sarah Yip, Ph.D. | Pioneers in Biomedical Research Seminar Series

Christine Brown, Ph.D.
Professor in the Department of Hematology and Hematopoietic Cell Transplantation; Heritage Provider Network Professor in Immunotherapy; and Deputy Director of the T Cell Therapeutics Research Laboratory, at City of Hope